← FDA Drug Approvals (Drugs@FDA)

DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE)

NDA · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2026-05-22

Drug application

FDA Application #

NDA220736

Application type

New Drug Application

Brand name

DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE)

Generic name

ADAPALENE AND BENZOYL PEROXIDE

Active ingredients

ADAPALENE, BENZOYL PEROXIDE

Dosage form

GEL

Route

—

Marketing status

Over-the-counter

Sponsor

GALDERMA LABS LP

Manufacturer

Galderma Laboratories, L.P.

First approval

2026-05-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown